D07.60
Carcinoma in situ of unspecified male genital organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the male genital organs is a type of early-stage cancer that has not yet invaded deeper tissues. The term 'in situ' indicates that the abnormal cells are confined to the layer of tissue where they originated and have not spread. When the specific organ is not identified, the diagnosis is recorded as carcinoma in situ of unspecified male genital organs (ICD-10 code D07.60). This condition typically requires prompt evaluation and management to prevent progression to invasive cancer.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal cell growth Exposure to carcinogens such as tobacco smoke or certain chemicals Chronic inflammatory conditions affecting the genital area Human papillomavirus (HPV) infection, which has been linked to some genital cancers Poor hygiene or chronic irritation in the genital region
Key Symptoms: Often asymptomatic, especially in early stages Visible lesions or abnormal growths on the skin or mucous membranes of the genital region Possible presence of a small, reddish, or whitish lesion Discomfort or itching in the affected area Bleeding or ulceration in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough physical examination followed by biopsy of any suspicious lesions. Pathological analysis confirms the presence of carcinoma in situ cells confined to the epithelium. Additional assessments may include imaging studies such as ultrasound or MRI to rule out invasion or spread, although in situ cancers are localized. Healthcare providers may also perform tests for HPV or other infections associated with genital cancers.
Treatment Protocols: Treatment options aim to eradicate abnormal cells and prevent progression to invasive cancer, often involving:
Clinical Advice & FAQs
Billing Guidance
Is D07.60 a billable ICD-10 code?
Yes, D07.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D07.60?
Clinical documentation must specify the nature of Carcinoma in situ of unspecified male genital organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
